The future of the global biopsy device market looks promising with opportunities in the breast biopsy, lung biopsy, colorectal biopsy, and prostate biopsy markets. The global biopsy device market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and increasing demand for minimally invasive procedures.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the biopsy device market by
product (needle-based biopsy devices, localization wires, procedure trays, and
others), guidance technique (ultrasound-guided biopsy, stereotactic-guided
biopsy, MRI-guided biopsy, and others), application (breast biopsy, lung
biopsy, colorectal biopsy, prostate biopsy, and others), end use (hospitals,
academic and research institutes, and diagnostic and imaging centers), and
region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will
grow at a faster pace and why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the
emerging trends in this market and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, needle
based biopsy instrument, liquid biopsy instrument, localization wire, biopsy
forcep, procedure tray, and biopsy table are the major segments of biopsy
device market by product. Lucintel forecasts that needle-based biopsy instrument
is expected to witness the highest growth over the forecast period.Within this
market, breast biopsy is expected to witness the highest growth over the
forecast period.
North America is
expected to witness highest growth over the forecast period.
Cook Medical, Boston
Scientific, Fujifilm, Cardinal Health, and Danaher are the major suppliers in
the biopsy device market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Explore Our Latest Publications
No comments:
Post a Comment